Factors predicting the response to low-dose methotrexate therapy in patients with rheumatoid arthritis : a better response in male patients
スポンサーリンク
概要
- 論文の詳細を見る
- 2004-12-01
著者
-
Kameda Hideto
Department Of Rheumatology And Clinical Immunology Saitama Medical Center Saitama Medical University
-
Takeuchi Tsutomu
Department Of Rheumatology And Clinical Immunology Saitama Medical Center Saitama Medical University
-
TAKEUCHI Tsutomu
Second Department of Internal Medicine, Saitama Medical Center, Saitama Medical School
-
AMANO Koichi
Division of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University
-
Amano Koichi
Department Of Rheumatology And Clinical Immunology Saitama Medical Center Saitama Medical University
-
Amano Koichi
Second Department Of Internal Medicine Saitama Medical Center
-
KAMEDA Hideto
Second Department of Internal Medicine, Saitama Medical Center
-
SEKIGUCHI Naoya
Second Department of Internal Medicine, Saitama Medical Center
-
TAKEI Hirofumi
Second Department of Internal Medicine, Saitama Medical Center
-
OGAWA Hiroe
Second Department of Internal Medicine, Saitama Medical Center
-
NAGASAWA Hayato
Second Department of Internal Medicine, Saitama Medical Center
-
Kameda Hideto
Division Of Rheumatology Saitama Medical Center Saitama Medical School
-
Ogawa Hiroe
Division Of Rheumatology/clinical Immunology Department Of Internal Medicine Saitama Medical Center
-
Takei Hirofumi
Division Of Rheumatology/clinical Immunology Department Of Internal Medicine Saitama Medical Center
-
Sekiguchi Naoya
Department Of Rheumatology And Clinical Immunology Saitama Medical Center Saitama Medical University
-
Amano Kouichi
Division Of Rheumatology Saitama Medical Center Saitama Medical School
-
Nagaoka Shouhei
Department Of Rheumatology Yokohama Minami Kyosai Hospital
-
Kameda Hideto
Department Of Rheumatology/clinical Immunology Saitama Medical Center
-
Takeuchi Tsutomu
Second Department Of Internal Medicine Saitama Medical Center
-
Nagasawa Hayato
Department Of Rheumatology And Clinical Immunology Saitama Medical Center Saitama Medical University
関連論文
- Rapid Proliferation of a Different Clone Early after Autologous Peripheral Blood Stem Cell Transplantation for Non-Hodgkin's Lymphoma
- Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis
- Successful Non-Surgical Treatment of Brain Abscess and Necrotizing Fasciitis Caused by Bacillus cereus
- Diagnosis of measles viral pneumonia in a patient with Hodgkin's disease by reverse transcription-polymerase chain reaction of serum
- T-cell receptor ζmRNA with an alternatively spliced 3' untranslated region is generated predominantly in the peripheral blood T cells of systemic lupus erythematosus patients
- Defective signal transduction via TCR-CD3 complex in patients with SLE
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan : one-year outcome of joint destruction (RECONFIRM-2J)
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan : one-year clinical outcomes (RECONFIRM-2)
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan (RECONFIRM)
- Differences between the Health Assessment Questionnaire Disability Index (HAQ-DI) and the modified HAQ (mHAQ) score before and after infliximab treatment in patients with rheumatoid arthritis
- Improvement of the HAQ score by infliximab treatment in patients with RA : its association with disease activity and joint destruction
- Development and validation of handy rheumatoid activity score with 38 joints (HRAS38) in rheumatoid arthritis patients receiving infliximab
- Impact of TNF inhibitors on rheumatoid arthritis
- Efficacy and safety of bucillamine, a D-penicillamine analogue, in patients with active rheumatoid arthritis
- Anti-TNF Biological Agents in Rheumatoid Arthritis and Other Inflammatory Diseases
- Factors predicting the response to low-dose methotrexate therapy in patients with rheumatoid arthritis : a better response in male patients
- The efficacy and safety of bucillamine as a second-line DMARD in the treatment of rheumatoid arthritis : a retrospective cohort study
- Notable Difference between the Development of Vertebral Fracture and Osteonecrosis of the Femoral Head in Patients Treated with High-dose Glucocorticoids for Systemic Rheumatic Diseases
- Scoring analysis of salivary gland scintigraphy in patients with Sjogren's syndrome
- Candida pneumonia in a case of polymyositis complicated with interstitial pneumonitis
- Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy : a randomized trial
- Usefulness of actarit in elderly rheumatoid arthritis
- Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan : results from a retrospective study (REACTION study)
- Structural damages disturb functional improvement in patients with rheumatoid arthritis treated with etanercept
- Effectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis : retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study)
- A Case of Multiple Giant Coronary Aneurysms and Abdominal Aortic Aneurysm Coexisting with IgG4-related Disease
- Successful Treatment of Class IV+V Lupus Nephritis with Combination Therapy of High-dose Corticosteroids, Tacrolimus and Intravenous Cyclophosphamide
- Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis : a retrospective review of 15 cases and analysis of risk factors
- Successful Non-Surgical Treatment of Brain Abscess and Necrotizing Fasciitis Caused by Bacillus cereus.
- A retrospective study of serum KL-6 levels during treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients : a report from the Ad Hoc Committee for Safety of Biological DMARDs of the Japan College of Rheumatology